Pages that link to "Q37892323"
Jump to navigation
Jump to search
The following pages link to Immunoglobulin A: A next generation of therapeutic antibodies? (Q37892323):
Displaying 29 items.
- Neutrophils in Cancer: Two Sides of the Same Coin (Q26773072) (← links)
- The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity (Q34218284) (← links)
- The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease (Q34499286) (← links)
- Monomeric IgA can be produced in planta as efficient as IgG, yet receives different N-glycans (Q35241502) (← links)
- Impact of IgA constant domain on HIV-1 neutralizing function of monoclonal antibody F425A1g8. (Q36487349) (← links)
- Structure and function relationships in IgA. (Q37936765) (← links)
- Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond (Q37998314) (← links)
- Fc-fusion proteins: new developments and future perspectives. (Q38029985) (← links)
- Vaccination for the prevention and treatment of breast cancer with special focus on Her-2/neu peptide vaccines. (Q38076053) (← links)
- Using glyco-engineering to produce therapeutic proteins. (Q38547311) (← links)
- Comparative analysis of plant-produced, recombinant dimeric IgA against cell wall β-glucan of pathogenic fungi (Q38612388) (← links)
- Cross-talk between pathogen recognizing Toll-like receptors and immunoglobulin Fc receptors in immunity (Q38615394) (← links)
- Neutrophils in cancer (Q38936555) (← links)
- Immunoglobulin Glycosylation Effects in Allergy and Immunity (Q38994739) (← links)
- Enhanced FcαRI-mediated neutrophil migration towards tumour colonies in the presence of endothelial cells (Q39358478) (← links)
- Transient Glyco-Engineering to Produce Recombinant IgA1 with Defined N- and O-Glycans in Plants (Q40011916) (← links)
- IgA attenuates anaphylaxis and subsequent immune responses in mice: possible application of IgA to vaccines (Q42247348) (← links)
- Insights from Fc receptor biology: a route to improved antibody reagents (Q43177854) (← links)
- Myeloid cells as effector cells for monoclonal antibody therapy of cancer. (Q46027197) (← links)
- The Development and Inmmunochemical Properties of the Dimer of Immunoglobulin A Specific to the Influenza Virus A Hemagglutinin. (Q54256333) (← links)
- The Development and Study of Recombinant Immunoglobulin A to Hemagglutinins of the Influenza Virus (Q59354380) (← links)
- IgA and FcαRI: Pathological Roles and Therapeutic Opportunities (Q64060912) (← links)
- Allosteric Effects between the Antibody Constant and Variable Regions: A Study of IgA Fc Mutations on Antigen Binding (Q90212270) (← links)
- Maternal gatekeepers: How maternal antibody Fc characteristics influence passive transfer and infant protection (Q90666469) (← links)
- IgA: Structure, Function, and Developability (Q91811769) (← links)
- Production, characterization, and in vivo half-life extension of polymeric IgA molecules in mice (Q92248471) (← links)
- Discovery and characterization of single-domain antibodies for polymeric Ig receptor-mediated mucosal delivery of biologics (Q92449492) (← links)
- Tumour-associated neutrophils in patients with cancer (Q92502928) (← links)
- A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction (Q98623621) (← links)